InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
Product | Citation | Year | Journal | Authors | Page |
---|---|---|---|---|---|
Primocin® | Supplemental Material: IL-20 controls resolution of experimental colitis by r... | 2023 | Gut | Chiriac M.T. et al. | DOI: 10.1136/gutjnl-2023-329628 |
NLRP3 inflammasome inhibitor - MCC950 | E-selectin-mediated rapid NLRP3 inflammasome activation regulates S100A8/S100... | 2023 | Nat Immunol. | Pruenster M. et al. | DOI: 10.1038/s41590-023-01656-1 |
Caspase-1 and Caspase-4 inhibitor | E-selectin-mediated rapid NLRP3 inflammasome activation regulates S100A8/S100... | 2023 | Nat Immunol. | Pruenster M. et al. | DOI: 10.1038/s41590-023-01656-1 |
Nigericin | E-selectin-mediated rapid NLRP3 inflammasome activation regulates S100A8/S100... | 2023 | Nat Immunol. | Pruenster M. et al. | DOI: 10.1038/s41590-023-01656-1 |
RAW-Lucia™ ISG-KO-STING Cells | Synergistic Effects of Azithromycin and STING Agonist Promote IFN-I Productio... | 2023 | J Exp Pharmacol. | Petcharat K. et al. | DOI: 10.2147/JEP.S433181 |
DMXAA | Synergistic Effects of Azithromycin and STING Agonist Promote IFN-I Productio... | 2023 | J Exp Pharmacol. | Petcharat K. et al. | DOI: 10.2147/JEP.S433181 |
Normocin® - Antimicrobial Reagent | Synergistic Effects of Azithromycin and STING Agonist Promote IFN-I Productio... | 2023 | J Exp Pharmacol. | Petcharat K. et al. | DOI: 10.2147/JEP.S433181 |
RAW-Lucia™ ISG Cells | Synergistic Effects of Azithromycin and STING Agonist Promote IFN-I Productio... | 2023 | J Exp Pharmacol. | Petcharat K. et al. | DOI: 10.2147/JEP.S433181 |
QUANTI-Luc™: Luciferase Detection Reagent | Synergistic Effects of Azithromycin and STING Agonist Promote IFN-I Productio... | 2023 | J Exp Pharmacol. | Petcharat K. et al. | DOI: 10.2147/JEP.S433181 |
CD40L Reporter HEK 293 Cells | Unbiased assessment of genome integrity and purging of adverse outcomes at th... | 2023 | EMBO J. | Canarutto D. et al. | DOI: 10.15252/embj.2023114188 |
Recombinant human CD40L protein | Unbiased assessment of genome integrity and purging of adverse outcomes at th... | 2023 | EMBO J. | Canarutto D. et al. | DOI: 10.15252/embj.2023114188 |
Anti-hIL-1β-IgG | Unbiased assessment of genome integrity and purging of adverse outcomes at th... | 2023 | EMBO J. | Canarutto D. et al. | DOI: 10.15252/embj.2023114188 |
Anti-TNF-α (Adalimumab biosimilar - IgG1 isotype) | Unbiased assessment of genome integrity and purging of adverse outcomes at th... | 2023 | EMBO J. | Canarutto D. et al. | DOI: 10.15252/embj.2023114188 |
QUANTI-Blue™ | Unbiased assessment of genome integrity and purging of adverse outcomes at th... | 2023 | EMBO J. | Canarutto D. et al. | DOI: 10.15252/embj.2023114188 |
MycoStrip® - Mycoplasma Detection Kit | Novel Indolyl-Benzimidazole Compounds Promote in vitro Wound Healing and Oste... | 2023 | Front Biosci (Landmark Ed). | Najafi S. et al. | DOI: 10.31083/j.fbl2810268 |
Caspase-1 and Caspase-4 inhibitor | Attenuates reactive oxygen species: induced pyroptosis via activation of the ... | 2023 | Sci Rep. | Liu M. et al. | DOI: 10.1038/s41598-023-44013-w |
Puromycin | The inhibitory effect of Gremlin-2 on adipogenesis suppresses breast cancer c... | 2023 | Breast Cancer Res. | Jung J. et al. | DOI: 10.1186/s13058-023-01732-2 |
Puromycin | Developing synthetic tools to decipher the tumor-immune interactome. | 2023 | PNAS | Weizman O.E. et al. | DOI: 10.1073/pnas.2306632120 |
Blasticidin | Developing synthetic tools to decipher the tumor-immune interactome. | 2023 | PNAS | Weizman O.E. et al. | DOI: 10.1073/pnas.2306632120 |
G418 (Geneticin) | Developing synthetic tools to decipher the tumor-immune interactome. | 2023 | PNAS | Weizman O.E. et al. | DOI: 10.1073/pnas.2306632120 |